CVE:HLS HLS Therapeutics Inc. (HLS.V) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding HLS Therapeutics Inc. (HLS.V) Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume49,300 shsAverage Volume97,793 shsMarket CapitalizationC$384.86 millionP/E RatioN/ADividend Yield1.46%BetaN/A ProfileAnalyst RatingsEarningsHeadlinesSocial Media HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and distributes pharmaceutical products in North American markets. It is focused on treatment products for the central nervous system and cardiovascular specialties. The company was incorporated in 2014 and is headquartered in Toronto, Canada.Read More MarketRank™Overall MarketRank™0.50 out of 5 starsAnalyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for HLS Therapeutics Inc. (HLS.V). Previous Next 2.5 Community Rank Outperform VotesHLS Therapeutics Inc. (HLS.V) has received 56 “outperform” votes. (Add your “outperform” vote.)Underperform VotesHLS Therapeutics Inc. (HLS.V) has received 54 “underperform” votes. (Add your “underperform” vote.)Community SentimentHLS Therapeutics Inc. (HLS.V) has received 50.91% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about HLS Therapeutics Inc. (HLS.V) and other stocks. Vote “Outperform” if you believe HLS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HLS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldHLS Therapeutics Inc. (HLS.V) has a dividend yield of 1.46%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthHLS Therapeutics Inc. (HLS.V) does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HLS Therapeutics Inc. (HLS.V) insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of HLS Therapeutics Inc. (HLS.V) is -14.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of HLS Therapeutics Inc. (HLS.V) is -14.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Industry, Sector and Symbol Stock Exchange CVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCVE:HLS Previous Symbol CUSIPN/A CIKN/A Webwww.hlstherapeutics.com Phone647-495-9000EmployeesN/A Debt Debt-to-Equity Ratio60.11 Current Ratio0.84 Quick Ratio0.75Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$65.13 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow38.84 Book ValueC$6.11 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Outstanding Shares27,295,300Market CapC$384.86 million Next Earnings DateN/A OptionableNot Optionable Receive HLS News and Ratings via Email Sign-up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. HLS Therapeutics Inc. (HLS.V) (CVE:HLS) Frequently Asked Questions What stocks does MarketBeat like better than HLS Therapeutics Inc. (HLS.V)? Wall Street analysts have given HLS Therapeutics Inc. (HLS.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but HLS Therapeutics Inc. (HLS.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Is HLS Therapeutics Inc. (HLS.V) a good dividend stock? HLS Therapeutics Inc. (HLS.V) pays an annual dividend of C$0.20 per share and currently has a dividend yield of 1.46%. View HLS Therapeutics Inc. (HLS.V)'s dividend history. Who are some of HLS Therapeutics Inc. (HLS.V)'s key competitors? Some companies that are related to HLS Therapeutics Inc. (HLS.V) include HEXO Corp. (HEXO.TO) (HEXO), Knight Therapeutics Inc. (GUD.TO) (GUD), OrganiGram Holdings Inc. (OGI.TO) (OGI), Benchmark Holdings plc (BMK.L) (BMK), Amryt Pharma plc (AMYT.L) (AMYT), ICC Labs Inc. (ICC.V) (ICC), The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGOD), ESSA Pharma Inc. (EPI.V) (EPI), Venture Life Group plc (VLG.L) (VLG), The Supreme Cannabis Company, Inc. (FIRE.TO) (FIRE), WeedMD Inc. (WMD.V) (WMD), Delta 9 Cannabis (NINE), Diurnal Group plc (DNL.L) (DNL), The Flowr Co. (FLWR.V) (FLWR) and Acerus Pharmaceuticals Co. (ASP.TO) (ASP). View all of HLS's competitors. What other stocks do shareholders of HLS Therapeutics Inc. (HLS.V) own? Based on aggregate information from My MarketBeat watchlists, some companies that other HLS Therapeutics Inc. (HLS.V) investors own include Allena Pharmaceuticals (ALNA), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB), ProMetic Life Sciences (PLI), Ritter Pharmaceuticals (RTTR), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE) and Apellis Pharmaceuticals (APLS). Who are HLS Therapeutics Inc. (HLS.V)'s key executives? HLS Therapeutics Inc. (HLS.V)'s management team includes the following people: Mr. William M. Wells M.B.A., B.A., MBA, Co-Founder & Exec. Chairman (Age 57)Mr. Gregory David Gubitz L.L.B., B.A., LL.B, Co-Founder, CEO & Director (Age 61)Mr. Gilbert Godin, Pres & COO (Age 59)Mr. Tim Hendrickson M.B.A., Chief Financial Officer (Age 47)Mr. Joseph Anthony MacLean B. Com., LL.B, Director of Corp. Devel. (Age 50) What is HLS Therapeutics Inc. (HLS.V)'s stock symbol? HLS Therapeutics Inc. (HLS.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HLS." How big of a company is HLS Therapeutics Inc. (HLS.V)? HLS Therapeutics Inc. (HLS.V) has a market capitalization of C$0.00 and generates C$65.13 million in revenue each year. What is HLS Therapeutics Inc. (HLS.V)'s official website? The official website for HLS Therapeutics Inc. (HLS.V) is www.hlstherapeutics.com. How can I contact HLS Therapeutics Inc. (HLS.V)? The company can be reached via phone at 647-495-9000. This page was last updated on 1/21/2021 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here
